Dimensional Fund Advisors
KROS icon

Dimensional Fund Advisors’s Keros Therapeutics KROS Stock Holding History

Dimensional Fund Advisors’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.6M Sell
403,603
-56,938
-12% -$623K ﹤0.01% 2520
2026
Q2 		$4.93M Buy
460,541
+139,181
+43% +$1.55M ﹤0.01% 2547
2026
Q1 		$3.55M Buy
321,360
+263,347
+454% +$4.07M ﹤0.01% 2589
2025
Q4 		$1.18M Buy
58,013
+22,055
+61% +$387K ﹤0.01% 2840
2025
Q3 		$569K Sell
35,958
-678
-2% -$10K ﹤0.01% 2972
2025
Q2 		$489K Hold
36,636
– – ﹤0.01% 2996
2025
Q1 		$374K Sell
36,636
-118,527
-76% -$1.38M ﹤0.01% 3036
2024
Q4 		$2.46M Buy
155,163
+2,727
+2% +$142K ﹤0.01% 2736
2024
Q3 		$8.85M Sell
152,436
-9,279
-6% -$458K ﹤0.01% 2352
2024
Q2 		$7.39M Sell
161,715
-3,691
-2% -$198K ﹤0.01% 2370
2024
Q1 		$10.9M Sell
165,406
-5,446
-3% -$323K ﹤0.01% 2270
2023
Q4 		$6.79M Sell
170,852
-425
-0.2% -$13.3K ﹤0.01% 2468
2023
Q3 		$5.46M Buy
171,277
+112,511
+191% +$4.2M ﹤0.01% 2503
2023
Q2 		$2.36M Buy
+58,766
New +$2.58M ﹤0.01% 2732

Other funds holding KROS

Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return

Dimensional Fund Advisors's KROS Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Keros Therapeutics (KROS) stake by 12% in Q3 2026, selling an estimated $623K and leaving 403,603 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2520.

Dimensional Fund Advisors first reported a position in KROS in Q2 2023 and has held it in 14 quarters since. The position peaked at $10.9M in Q1 2024. 57 funds tracked by Wall St. Rank hold KROS as of Q3 2026.

  • Dimensional Fund Advisors held 403,603 shares of Keros Therapeutics worth $4.6M as of Q3 2026.
  • Dimensional Fund Advisors sold 56,938 Keros Therapeutics shares in Q3 2026, an estimated $623K.
  • Keros Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2520 holding.
  • Dimensional Fund Advisors first reported a position in Keros Therapeutics in Q2 2023 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Keros Therapeutics position peaked at $10.9M in Q1 2024.
  • 57 funds tracked by Wall St. Rank held Keros Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.